Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTG-containing ART versus non-DTG ART in treatment-naive AIDS patients with opportunistic infection
ChiCTR1900025599Phase 4Not yet recruiting
- Sponsor
- Zhengzhou Sixth People's Hospital
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dolutegravir in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS) (2 arms), sponsored by Zhengzhou Sixth People's Hospital. Primary endpoints: Lymphocyte subset and HIV-1 viral load. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on ChiCTR1900025599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025599.